Padraic O'Malley

CHIEF & CLIN ASO PROF

MD-UROLOGY

  • CHIEF & CLIN ASO PROF
    MD-UROLOGY

GRANTS

  • GRANT
    A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-grade Upper Tract Urothelial Cancer (LG-UTUC)
    Urogen Pharma Ltd12 Sep 2025 - 11 Sep 2030
    Active
  • GRANT
    A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Cg Oncology24 Jun 2025 - 23 Jun 2030
    Active
  • GRANT
    GAIN-BCG: Gemcitabine Alternating with INtravesical BCG randomized against BCG alone for patients with recurrent high grade Non-Muscle Invasive Bladder Cancer
    National Institute of Health Nci5 Jun 2025 - 28 Feb 2029
    Active
  • GRANT
    Salvage Focal Therapy via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer (FocalHIFU) (NCT06402357)
    Edap Technomed18 Nov 2024 - 17 Nov 2029
    Active
  • GRANT
    a multi- center registry under a protocol entitled “uTRACT Registry Jelmyto® (mitomycin) for pyelocalyceal solution (the “Drug”)
    Urogen Ltd6 Aug 2024 - 5 Aug 2029
    Active
  • GRANT
    A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer
    Surge Therapeutics9 May 2024 - 8 May 2029
    Active
  • GRANT
    A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)
    National Institute of Health Nci5 Jan 2023 - 28 Feb 2029
    Active
  • GRANT
    Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
    Angiodynamics25 Apr 2022 - 30 Jan 2024
    Closed
  • GRANT
    Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
    Angiodynamics25 Apr 2022 - 13 May 2025
    Closed
  • GRANT
    A 3-arm randomized controlled trial evaluating the role of 29MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer
    Exact Imaging6 Apr 2022 - 16 May 2025
    Closed
  • GRANT
    A 3-arm randomized controlled trial evaluating the role of 29MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer
    Exact Imaging6 Apr 2022 - 4 May 2026
    Expired
  • GRANT
    Phase III Trial of Immunotherapy-Based Combination Therapy with or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE trial)
    National Institute of Health Nci16 Nov 2020 - 28 Feb 2029
    Active